Mitsubishi UFJ Asset Management Portfolio holdings
AUM
$125B
1-Year Return
23.89%
This Quarter Return
+8.91%
1 Year Return
+23.89%
3 Year Return
+93.04%
5 Year Return
+163.06%
10 Year Return
+400.91%
AUM
$47.9B
AUM Growth
+$5.83B
(+14%)
Cap. Flow
+$2.66B
Cap. Flow
% of AUM
5.56%
Top 10 Holdings %
Top 10 Hldgs %
27.7%
Holding
1,160
New
43
Increased
790
Reduced
196
Closed
50
Top Buys
| 1 |
Arthur J. Gallagher & Co
AJG
|
+$249M |
| 2 |
Apple
AAPL
|
+$162M |
| 3 |
Accenture
ACN
|
+$136M |
| 4 |
IQVIA
IQV
|
+$109M |
| 5 |
Thermo Fisher Scientific
TMO
|
+$82.6M |
Top Sells
| 1 |
Medtronic
MDT
|
+$244M |
| 2 |
Baxter International
BAX
|
+$154M |
| 3 |
Adobe
ADBE
|
+$97.6M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$71.6M |
| 5 |
Microsoft
MSFT
|
+$59.8M |
Sector Composition
| 1 | Technology | 29.5% |
| 2 | Healthcare | 16.05% |
| 3 | Financials | 13.31% |
| 4 | Consumer Discretionary | 8.72% |
| 5 | Industrials | 7.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
GMRE
976
Global Medical REIT
GMRE
$505M
| $344K | ﹤0.01% |
37,656
+7,654
| +26% | +$69.9K |
|
977
OmniAb
OABI
$226M
| $341K | ﹤0.01% |
+67,794
| New | +$341K |
|
978
Vontier
VNT
$6.25B
| $340K | ﹤0.01% |
10,560
| – | – |
|
|
DHC
979
Diversified Healthcare Trust
DHC
$1.03B
| $337K | ﹤0.01% |
149,606
| – | – |
|
980
Mercury Systems
MRCY
$4.12B
| $336K | ﹤0.01% |
9,719
-139
| -1% | -$4.81K |
|
|
HUT
981
Hut 8
HUT
$3.09B
| $326K | ﹤0.01% |
19,765
-13,133
| -40% | -$217K |
|
982
Krystal Biotech
KRYS
$4.09B
| $320K | ﹤0.01% |
2,724
-752
| -22% | -$88.3K |
|
983
Merus
MRUS
$5.18B
| $320K | ﹤0.01% |
12,136
-4,378
| -27% | -$115K |
|
|
LAND
984
Gladstone Land Corp
LAND
$322M
| $316K | ﹤0.01% |
19,400
+4,226
| +28% | +$68.8K |
|
|
GOOD
985
Gladstone Commercial Corp
GOOD
$605M
| $312K | ﹤0.01% |
25,210
+5,648
| +29% | +$69.9K |
|
|
BFS
986
Saul Centers
BFS
$792M
| $311K | ﹤0.01% |
8,452
+1,957
| +30% | +$72.1K |
|
987
CureVac
CVAC
$1.21B
| $300K | ﹤0.01% |
28,800
-4,025
| -12% | -$41.9K |
|
988
Arcturus Therapeutics
ARCT
$487M
| $294K | ﹤0.01% |
10,247
-6,581
| -39% | -$189K |
|
|
VERV
989
DELISTED
Verve Therapeutics
VERV
| $293K | ﹤0.01% |
+15,608
| New | +$293K |
|
|
CLDT
990
Chatham Lodging
CLDT
$350M
| $291K | ﹤0.01% |
31,108
+7,145
| +30% | +$66.9K |
|
991
ICICI Bank
IBN
$114B
| $290K | ﹤0.01% |
12,570
+663
| +6% | +$15.3K |
|
|
HPP
992
Hudson Pacific Properties
HPP
$1.11B
| $288K | ﹤0.01% |
68,136
| – | – |
|
|
CBL
993
CBL Properties
CBL
$990M
| $286K | ﹤0.01% |
12,962
| – | – |
|
994
Marathon Digital Holdings
MARA
$5.9B
| $283K | ﹤0.01% |
20,386
-10,342
| -34% | -$143K |
|
|
WSR
995
Whitestone REIT
WSR
$654M
| $279K | ﹤0.01% |
28,730
| – | – |
|
996
Amicus Therapeutics
FOLD
$2.43B
| $275K | ﹤0.01% |
21,910
-3,922
| -15% | -$49.3K |
|
997
Regenxbio
RGNX
$500M
| $273K | ﹤0.01% |
13,669
+666
| +5% | +$13.3K |
|
|
SOL
998
Emeren Group
SOL
$96.5M
| $272K | ﹤0.01% |
71,839
-77,028
| -52% | -$292K |
|
999
Novavax
NVAX
$1.29B
| $271K | ﹤0.01% |
36,488
+23,704
| +185% | +$176K |
|
1000
Arrowhead Research
ARWR
$3.83B
| $269K | ﹤0.01% |
7,552
-1,085
| -13% | -$38.7K |
|